Trial of eRapa in Prostate Cancer Patients

NCT03618355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: eRapa (encapsulated rapamycin)

Sponsor

Rapamycin Holdings, Inc. dba Emtora Biosciences

Collaborators

[object Object]